Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
140.3 USD | +4.94% | +5.76% | +6.75% |
Apr. 17 | Nxera Pharma's Neuro Drug NBI-1117568 Passed Preclinical Toxicity Test | MT |
Apr. 16 | Neurocrine Biosciences, Sentia Medical Sciences Extend Partnership on Prospective Drug Development | MT |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.